Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated for Age-Related Macular Degeneration
Journal of the Korean Ophthalmological Society
;
: 1534-1539, 2013.
Article
in Korean
| WPRIM
| ID: wpr-12555
ABSTRACT
PURPOSE:
To investigate the development of new choroidal neovascularization in fellow eyes of patients treated for unilateral exudative age-related macular degeneration (AMD).METHODS:
Three hundred fourteen patients who were first diagnosed with unilateral exudative AMD and treated with intravitreal bevacizumab or ranibizumab were studied retrospectively.RESULTS:
New exudative AMD developed in 7.0% of fellow eyes after 1 year, 10.8% after 2 years and 13.7% after more than 2 years. According to the subtype of exudative AMD, there were no significant differences between classic CNV, occult or minimally classic CNV, and PCV in the incidence of new exudative AMD. After 2 years, a higher conversion rate was found in the bevacizumab-treated group than the ranibizumab-treated group.CONCLUSIONS:
The cumulative incidence of involvement in fellow eyes with exudative AMD was 13.7% over 2 years.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Incidence
/
Choroid
/
Choroidal Neovascularization
/
Eye
/
Antibodies, Monoclonal, Humanized
/
Bevacizumab
/
Ranibizumab
/
Macular Degeneration
Type of study:
Incidence study
/
Prognostic study
Limits:
Humans
Language:
Korean
Journal:
Journal of the Korean Ophthalmological Society
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS